• Tue, August 30, 2016
  • Wed, August 31, 2016
  • Mon, September 5, 2016
  • Tue, September 6, 2016
  • Mon, August 29, 2016
  • Thu, September 1, 2016
  • Fri, September 2, 2016

Josh Schimmer Initiated (TBPH) at Strong Buy and Held Target at $41 on, Aug 29th, 2016

Josh Schimmer of Evercore ISI Group, Initiated "Theravance Biopharma, Inc." (TBPH) at Strong Buy and Held Target at $41 on, Aug 29th, 2016.

Josh, nor any peers, have made any analyst calls on TBPH in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30